The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
Planet Labs PBC
PL · the NYSE · USD · Market cap $6.1B · 945 employees
Planet Labs PBC engages in the design, construction, and launch of constellations of satellites with the intent of providing high-cadence geospatial data delivered to customers through an online platform in the United St…
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Planet Labs PBC holds its Markdown at $16.69. The statistical read favours the sellers, held for 7 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 7 days |
| Price at the screen | $16.69 |
| Valuation | N/A trailing · -13,352.00 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 2.11 |
Five Screens, Shown in Full
Does not pass. Excluded industry: Aerospace & Defense
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Excluded industry: Aerospace & Defense | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 100.0% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +110% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsSatellites promise daily earth views but ethics block
Picture a fleet of small satellites beaming fresh photos of every corner of the globe each day. Planet Labs built that network to sell the data to governments and firms. We pass because the business fails our ethical screen on aerospace and defence work.
Revenue is growing fast yet the company still loses more than a dollar for every dollar earned, with returns on equity deeply negative. The shares trade well above our fair value and carry a forward multiple that leaves no margin for error. The narrow moat offers little protection against those realities.
Analyst price targets look optimistic on paper alone. The industry exclusion remains firm regardless of growth or sentiment. Analysis, not advice.
| Forward P/E | -13,352.0x |
| EPS, trailing | -1.10 |
| EPS, forward | 0.00 |
| Revenue growth | +58.1%growing very fast |
| Profit margin | -95.1%currently unprofitable |
| Return on equity | -72.0%not currently earning a positive return on equity |
| FCF yield | 0.85% |
| Debt to equity | 0.88moderate, manageable leverage |
| Current ratio | 2.84comfortably covers its short-term bills |
| Beta | 2.11much more volatile than the market |
| Short interest, float | 0.09% |
| 52-week range | 9.13 - 51.76 |
| Moat | NARROW |
| Market cap | $6.1B |
| Employees | 945 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradePL trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 5.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 27.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 92% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 450%. Our forward projection puts the odds of a 10% gain over the next month near 56%. The street (10 analysts) rates it buy, with a mean price target of $40.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Johnson Ashley F. | Pres, CFO | S - Sale | 55,663 | $944,312 |
| 2026-09-17 | Schingler Robert H | Co-Founder Chief Strategy Offi | S - Sale | 52,240 | $886,225 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-27 | Gil Cisneros | Democrat | buy | 15K–50K |
| 2026-08-27 | Gil Cisneros | Democrat | buy | 15K–50K |
| 2026-08-27 | Gil Cisneros | Democrat | buy | 15K–50K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $41.84 | -26.5% | · | $735 | -26.5% |
| 2 months | $34.67 | -11.3% | · | $887 | -11.3% |
| 3 months | $24.97 | +23.2% | · | $1,232 | +23.2% |
| 6 months | $17.47 | +76.1% | · | $1,761 | +76.1% |
| 1 year | $5.59 | +450.4% | · | $5,504 | +450.4% |
| 2 years | $2.07 | +1,386.2% | · | $14,862 | +1,386.2% |
| 3 years | $3.41 | +802.2% | · | $9,022 | +802.2% |
| 5 years | $9.95 | +209.0% | · | $3,090 | +209.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PL does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.